0001104659-21-145591.txt : 20211201 0001104659-21-145591.hdr.sgml : 20211201 20211201202502 ACCESSION NUMBER: 0001104659-21-145591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211129 FILED AS OF DATE: 20211201 DATE AS OF CHANGE: 20211201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cuca Roberto CENTRAL INDEX KEY: 0001591474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 211464613 MAIL ADDRESS: STREET 1: C/O TREVENA, INC. STREET 2: 1018 WEST 8TH AVENUE, SUITE A CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TELA Bio, Inc. CENTRAL INDEX KEY: 0001561921 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455320061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-320-2930 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 4 1 tm2134403d1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-29 0 0001561921 TELA Bio, Inc. TELA 0001591474 Cuca Roberto C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 0 1 0 0 COO and CFO Common Stock 2021-11-29 4 P 0 423 12.60 A 423 D Common Stock 2021-11-30 4 P 0 838 12.43 A 1261 D Common Stock 2021-12-01 4 P 0 1780 12.64 A 3041 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.41 to $12.74. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.40 to $12.49. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.55 to $12.65. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Roberto Cuca 2021-12-01